Skip to main content
Top
Published in: Current Diabetes Reports 1/2014

01-01-2014 | Diabetes and Pregnancy (CJ Homko, Section Editor)

Vitamin D and Gestational Diabetes Mellitus

Authors: Heather H. Burris, Carlos A. Camargo Jr.

Published in: Current Diabetes Reports | Issue 1/2014

Login to get access

Abstract

Gestational diabetes mellitus (GDM) complicates 7 %–14 % of pregnancies in the United States. Vitamin D deficiency also is common in pregnancy. Emerging evidence suggests that Vitamin D administration can improve insulin sensitivity and glucose tolerance, but whether vitamin D supplementation can prevent GDM is unknown. Observational studies provide conflicting evidence as to whether low serum 25-hydroxyvitmain D (25(OH)D) levels are associated with GDM. Two recent systematic reviews concluded that vitamin D deficiency is associated with a higher risk of GDM. However, these reviews are limited by the observational and diverse nature of the included studies. Of greatest concern is the inability to understand how important confounding variables such as race/ethnicity and adiposity might affect the association. Randomized controlled trial data remain limited but are critical to understanding whether supplementation with vitamin D beyond what is contained in routine prenatal vitamins will prevent GDM or improve glucose tolerance for women with GDM.
Literature
3.
go back to reference Hypponen E, Laara E, Reunanen A, et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 2001;358:1500–3.PubMedCrossRef Hypponen E, Laara E, Reunanen A, et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 2001;358:1500–3.PubMedCrossRef
4.
go back to reference Bourlon PM, Billaudel B, Faure-Dussert A. Influence of vitamin D3 deficiency and 1,25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. J Endocrinol. 1999;160:87–95.PubMedCrossRef Bourlon PM, Billaudel B, Faure-Dussert A. Influence of vitamin D3 deficiency and 1,25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. J Endocrinol. 1999;160:87–95.PubMedCrossRef
5.
go back to reference Cade C, Norman AW. Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology. 1986;119:84–90.PubMedCrossRef Cade C, Norman AW. Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology. 1986;119:84–90.PubMedCrossRef
6.
go back to reference Pittas AG, Lau J, Hu FB, et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92:2017–29.PubMedCentralPubMedCrossRef Pittas AG, Lau J, Hu FB, et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92:2017–29.PubMedCentralPubMedCrossRef
7.
go back to reference Ferrara A, Kahn HS, Quesenberry CP, et al. An increase in the incidence of gestational diabetes mellitus: Northern California, 1991–2000. Obstet Gynecol. 2004;103:526–33.PubMedCrossRef Ferrara A, Kahn HS, Quesenberry CP, et al. An increase in the incidence of gestational diabetes mellitus: Northern California, 1991–2000. Obstet Gynecol. 2004;103:526–33.PubMedCrossRef
8.
go back to reference Committee opinion no. 504: screening and diagnosis of gestational diabetes mellitus. Obstet Gynecol. 2011;118:751–3. Committee opinion no. 504: screening and diagnosis of gestational diabetes mellitus. Obstet Gynecol. 2011;118:751–3.
11.
go back to reference Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabet Med. 2004;21:103–13.PubMedCrossRef Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabet Med. 2004;21:103–13.PubMedCrossRef
12.
go back to reference Bardenheier BH, Elixhauser A, Imperatore G, et al. Variation in prevalence of gestational diabetes mellitus among hospital discharges for obstetric delivery across 23 States in the United States. Diabetes Care. 2013;36:1209–14.PubMedCrossRef Bardenheier BH, Elixhauser A, Imperatore G, et al. Variation in prevalence of gestational diabetes mellitus among hospital discharges for obstetric delivery across 23 States in the United States. Diabetes Care. 2013;36:1209–14.PubMedCrossRef
13.
go back to reference Harlev A, Wiznitzer A. New insights on glucose pathophysiology in gestational diabetes and insulin resistance. Curr Diab Rep. 2010;10:242–7.PubMedCrossRef Harlev A, Wiznitzer A. New insights on glucose pathophysiology in gestational diabetes and insulin resistance. Curr Diab Rep. 2010;10:242–7.PubMedCrossRef
14.
go back to reference Dror DK. Vitamin D, status during pregnancy: maternal, fetal, and postnatal outcomes. Curr Opin Obstet Gynecol. 2011;23:422–6.PubMedCrossRef Dror DK. Vitamin D, status during pregnancy: maternal, fetal, and postnatal outcomes. Curr Opin Obstet Gynecol. 2011;23:422–6.PubMedCrossRef
15.
go back to reference Ozfirat Z, Chowdhury TA. Vitamin D deficiency and type 2 diabetes. Postgrad Med J. 2010;86:18–25. quiz 4.PubMedCrossRef Ozfirat Z, Chowdhury TA. Vitamin D deficiency and type 2 diabetes. Postgrad Med J. 2010;86:18–25. quiz 4.PubMedCrossRef
16.
go back to reference Chu SY, Callaghan WM, Kim SY, et al. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care. 2007;30:2070–6.PubMedCrossRef Chu SY, Callaghan WM, Kim SY, et al. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care. 2007;30:2070–6.PubMedCrossRef
17.
go back to reference Solomon CG, Willett WC, Carey VJ, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA. 1997;278:1078–83.PubMedCrossRef Solomon CG, Willett WC, Carey VJ, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA. 1997;278:1078–83.PubMedCrossRef
18.
go back to reference Parikh SJ, Edelman M, Uwaifo GI, et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab. 2004;89:1196–9.PubMedCrossRef Parikh SJ, Edelman M, Uwaifo GI, et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab. 2004;89:1196–9.PubMedCrossRef
19.
go back to reference Cheng S, Massaro JM, Fox CS, et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes. 2009;59:242–8.PubMedCrossRef Cheng S, Massaro JM, Fox CS, et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes. 2009;59:242–8.PubMedCrossRef
20.
go back to reference Soheilykhah S, Mojibian M, Rashidi M, et al. Maternal vitamin D status in gestational diabetes mellitus. Nutr Clin Pract. 2010;25:524–7.PubMedCrossRef Soheilykhah S, Mojibian M, Rashidi M, et al. Maternal vitamin D status in gestational diabetes mellitus. Nutr Clin Pract. 2010;25:524–7.PubMedCrossRef
21.
go back to reference Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84:18–28.PubMed Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84:18–28.PubMed
22.
go back to reference Ginde AA, Sullivan AF, Mansbach JM, et al. Vitamin D insufficiency in pregnant and nonpregnant women of childbearing age in the United States. Am J Obstet Gynecol. 2010;202:436 e1–8. Ginde AA, Sullivan AF, Mansbach JM, et al. Vitamin D insufficiency in pregnant and nonpregnant women of childbearing age in the United States. Am J Obstet Gynecol. 2010;202:436 e1–8.
23.
go back to reference Holmes VA, Barnes MS, Alexander HD, et al. Vitamin D deficiency and insufficiency in pregnant women: a longitudinal study. Br J Nutr. 2009;102:876–81.PubMedCrossRef Holmes VA, Barnes MS, Alexander HD, et al. Vitamin D deficiency and insufficiency in pregnant women: a longitudinal study. Br J Nutr. 2009;102:876–81.PubMedCrossRef
24.
go back to reference van den Ouweland JM, Beijers AM, Demacker PN, et al. Measurement of 25-OH-vitamin D in human serum using liquid chromatography tandem-mass spectrometry with comparison with radioimmunoassay and automated immunoassay. J Chromatogr B Anal Technol Biomed Life Sci. 2010;878:1163–8.CrossRef van den Ouweland JM, Beijers AM, Demacker PN, et al. Measurement of 25-OH-vitamin D in human serum using liquid chromatography tandem-mass spectrometry with comparison with radioimmunoassay and automated immunoassay. J Chromatogr B Anal Technol Biomed Life Sci. 2010;878:1163–8.CrossRef
25.
go back to reference Clifton-Bligh RJ, McElduff P, McElduff A. Maternal vitamin D deficiency, ethnicity and gestational diabetes. Diabet Med. 2008;25:678–84.PubMedCrossRef Clifton-Bligh RJ, McElduff P, McElduff A. Maternal vitamin D deficiency, ethnicity and gestational diabetes. Diabet Med. 2008;25:678–84.PubMedCrossRef
26.
go back to reference Hossein-Nezhad A, Maghbooli Z, Vassigh AR, et al. Prevalence of gestational diabetes mellitus and pregnancy outcomes in Iranian women. Taiwan J Obstet Gynecol. 2007;46:236–41.PubMedCrossRef Hossein-Nezhad A, Maghbooli Z, Vassigh AR, et al. Prevalence of gestational diabetes mellitus and pregnancy outcomes in Iranian women. Taiwan J Obstet Gynecol. 2007;46:236–41.PubMedCrossRef
27.
go back to reference Zhang C, Qiu C, Hu FB, et al. Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus. PLoS One. 2008;3:e3753.PubMedCentralPubMedCrossRef Zhang C, Qiu C, Hu FB, et al. Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus. PLoS One. 2008;3:e3753.PubMedCentralPubMedCrossRef
28.
go back to reference Farrant HJ, Krishnaveni GV, Hill JC, et al. Vitamin D insufficiency is common in Indian mothers but is not associated with gestational diabetes or variation in newborn size. Eur J Clin Nutr. 2009;63:646–52.PubMedCentralPubMedCrossRef Farrant HJ, Krishnaveni GV, Hill JC, et al. Vitamin D insufficiency is common in Indian mothers but is not associated with gestational diabetes or variation in newborn size. Eur J Clin Nutr. 2009;63:646–52.PubMedCentralPubMedCrossRef
29.
go back to reference Makgoba M, Nelson SM, Savvidou M, et al. First-trimester circulating 25-hydroxyvitamin d levels and development of gestational diabetes mellitus. Diabetes Care. 2011;34:1091–3.PubMedCrossRef Makgoba M, Nelson SM, Savvidou M, et al. First-trimester circulating 25-hydroxyvitamin d levels and development of gestational diabetes mellitus. Diabetes Care. 2011;34:1091–3.PubMedCrossRef
31.••
go back to reference Wei SQ, Qi HP, Luo ZC, et al. Maternal vitamin D status and adverse pregnancy outcomes: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2013;26(9):889-99. 10.3109/14767058.2013.765849 .Recently published systematic review of 25(OH)D levels and pregnancy outcomes including a meta-analysis for GDM. The authors included 12 studies of 5615 participants and found that among women with 25(OH)D levels <50 nmol/L increase in odds of GDM (Fig. 1). Wei SQ, Qi HP, Luo ZC, et al. Maternal vitamin D status and adverse pregnancy outcomes: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2013;26(9):889-99. 10.​3109/​14767058.​2013.​765849 .Recently published systematic review of 25(OH)D levels and pregnancy outcomes including a meta-analysis for GDM. The authors included 12 studies of 5615 participants and found that among women with 25(OH)D levels <50 nmol/L increase in odds of GDM (Fig. 1).
32.••
go back to reference Aghajafari F, Nagulesapillai T, Ronksley PE, et al. Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies. BMJ. 2013;346:f1169. Another recently published systematic review of vitamin D status and pregnancy outcomes including a meta-analysis of 10 studies of 25(OH)D levels and the risk of GDM. They concluded that women with 25(OH)D levels <75 nmol/L had higher odds of GDM (Fig. 1.).PubMedCrossRef Aghajafari F, Nagulesapillai T, Ronksley PE, et al. Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies. BMJ. 2013;346:f1169. Another recently published systematic review of vitamin D status and pregnancy outcomes including a meta-analysis of 10 studies of 25(OH)D levels and the risk of GDM. They concluded that women with 25(OH)D levels <75 nmol/L had higher odds of GDM (Fig. 1.).PubMedCrossRef
33.
go back to reference Wei SQ, Qi HP, Luo ZC, et al. Maternal vitamin D status and adverse pregnancy outcomes: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2013;26:889–99.PubMedCrossRef Wei SQ, Qi HP, Luo ZC, et al. Maternal vitamin D status and adverse pregnancy outcomes: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2013;26:889–99.PubMedCrossRef
35.
go back to reference Rudnicki PM, Molsted-Pedersen L. Effect of 1,25-dihydroxycholecalciferol on glucose metabolism in gestational diabetes mellitus. Diabetologia. 1997;40:40–4.PubMedCrossRef Rudnicki PM, Molsted-Pedersen L. Effect of 1,25-dihydroxycholecalciferol on glucose metabolism in gestational diabetes mellitus. Diabetologia. 1997;40:40–4.PubMedCrossRef
36.•
go back to reference Soheilykhah S, Mojibian M, Moghadam MJ, et al. The effect of different doses of vitamin D supplementation on insulin resistance during pregnancy. Gynecol Endocrinol. 2013;29:396–9. This is a recent trial of various doses of vitamin D supplementation with measurement of insulin resistance among nondiabetic pregnant women. Findings included similar glucose concentrations across groups, but lower insulin levels among women with higher doses of vitamin D supplementation, suggesting increased insulin sensitivity (Table 1).PubMedCrossRef Soheilykhah S, Mojibian M, Moghadam MJ, et al. The effect of different doses of vitamin D supplementation on insulin resistance during pregnancy. Gynecol Endocrinol. 2013;29:396–9. This is a recent trial of various doses of vitamin D supplementation with measurement of insulin resistance among nondiabetic pregnant women. Findings included similar glucose concentrations across groups, but lower insulin levels among women with higher doses of vitamin D supplementation, suggesting increased insulin sensitivity (Table 1).PubMedCrossRef
37.
go back to reference Nesby-O’Dell S, Scanlon KS, Cogswell ME, et al. Hypovitaminosis D prevalence and determinants among African American and White women of reproductive age: Third National Health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr. 2002;76:187–92.PubMed Nesby-O’Dell S, Scanlon KS, Cogswell ME, et al. Hypovitaminosis D prevalence and determinants among African American and White women of reproductive age: Third National Health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr. 2002;76:187–92.PubMed
39.
go back to reference ACOG Comittee on Obstetric Practice. ACOG Committee Opinion No. 495. Vitamin D: screening and supplementation during pregnancy. Obstet Gynecol. 2011;118:197–8.CrossRef ACOG Comittee on Obstetric Practice. ACOG Committee Opinion No. 495. Vitamin D: screening and supplementation during pregnancy. Obstet Gynecol. 2011;118:197–8.CrossRef
Metadata
Title
Vitamin D and Gestational Diabetes Mellitus
Authors
Heather H. Burris
Carlos A. Camargo Jr.
Publication date
01-01-2014
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 1/2014
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-013-0451-3

Other articles of this Issue 1/2014

Current Diabetes Reports 1/2014 Go to the issue

Pediatric Type 2 Diabetes (PS Zeitler, Section Editor)

Changing Epidemiology of Metabolic Syndrome and Type 2 Diabetes in Chinese Youth

Pediatric Type 2 Diabetes (PS Zeitler, Section Editor)

Depression and Quality of Life in Youth-Onset Type 2 Diabetes Mellitus

Pediatric Type 2 Diabetes (PS Zeitler, Section Editor)

Maternal and In Utero Determinants of Type 2 Diabetes Risk in the Young

Hospital Management of Diabetes (G Umpierrez, Section Editor)

Inpatient Hypoglycemia: A Challenge That Must Be Addressed

Pathogenesis of Type 2 Diabetes and Insulin Resistance (RM Watanabe, Section Editor)

Advanced Glycation End Products (AGE) and Diabetes: Cause, Effect, or Both?

Pediatric Type 2 Diabetes (PS Zeitler, Section Editor)

Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Obese Children

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.